LENZ Therapeutics and Théa Partner to Bring First Aceclidine-Based Eye Drop for Presbyopia to Canada
Canada preps for a presbyopia upgrade as LENZ100 edges closer to potential FDA approval. LENZ Therapeutics (San Diego, USA) and…
Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…
latest posts
